Search Results 481-490 of 23355 for B cell lymphomas
... B-Cell Lymphoma (DLBCL). The Effects of Acute and Chronic Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia ...
The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell malignancies ...
Large B-cell lymphoma with IRF4 gene rearrangements: Differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult ...
Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato ...
NOTE: patients with B-cell lymphoma with features intermediate between diffuse large B ... Relapsed/refractory primary vitreoretinal diffuse large B cell lymphoma ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
Immunoglobin heavy locus (IGH) somatic hypermutation analysis, B-cell chronic lymphocytic leukemia (B CLL ) ... cell lymphoma, which affects 5% to 15% of patients ...
Marginal zone lymphoma, B-cell lymphoma, Lymphoma, Hairy cell leukemia, T-cell lymphoma, Small lymphocytic lymphoma, Follicular lymphoma, Hodgkin lymphoma ...
... B-cell lymphoma 2 (BCL2) inhibitor. MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.